We are evaluating diagnostics that are fit for the needs of older patients. This builds on the North East’s international reputation for research excellence in ageing.
We are expanding our proficiency in evaluating diagnostic tests for infectious diseases. We are particularly focused on improved detection of sepsis and, more recently, COVID-19.
We are evaluating tests that identify patients who will respond to specific treatments. This will strengthen the North East's world leading expertise in cancer and inherited diseases.